Skip to main content

Kodiak Sciences Inc.

KOD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001468748

In the last 90 days, Kodiak Sciences Inc. insiders filed 3 open-market purchases and 0 sales; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Kodiak Sciences Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of KOD: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders106298−6
Shares40.1M3.89M39.4M+3.21M (+8.9%)
Value$94.3M$9.15M$103.0M+$17.9M (+21.0%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Kodiak Sciences Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to KOD in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.3,937,932$10.3M0.00%
Gsa Capital Partners LLP287,756$751.0K0.06%
Lynx1 Capital Management LP271,177$707.8K0.25%
RIA Advisory Group LLC73,257$191.2K0.07%
Nantahala Capital Management, LLC68,857$179.7K0.02%
AQR Capital Management LLC35,537$92.8K0.00%
Cerity Partners LLC16,759$43.7K0.00%
SG Americas Securities, LLC12,813$33.0K0.00%
Price T Rowe Associates Inc11,446$30.0K0.00%
Cornerstone Planning Group LLC210$8250.00%
Citadel Advisors LLC169$4410.00%
Sterling Capital Management LLC102$2660.00%

Sold out (18)

Institutions that held Kodiak Sciences Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held Kodiak Sciences Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KOD in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.3,846,827$9.04M
Susquehanna Fundamental Investments, LLC47,616$111.9K